Trial NCT03176264

View at ClinicalTrials.gov 
Org. Study IDs: CPDR001I2101
Secondary IDs: 2017-000520-96

Last trial update was posted on 2021-10-12

MeSH Interventions

Bevacizumab Spartalizumab

MeSH Conditions

Colorectal Neoplasms

Other Conditions

Metastatic Colorectal Cancer

Stopping Reasons

The study was terminated early due to company decision.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID